IL-27-Induced Gene Expression Is Downregulated in HIV-Infected Subjects

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Guzzo, Christina ^a   Hopman, Wilma M ^a   Che Mat, Nor Fazila ^a,b   Wobeser, Wendy ^a   Gee, Katrina ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 10; INTERLEUKIN 27; INTERLEUKIN 27 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; MESSENGER RNA; PROTEIN WSX 1; RECEPTOR SUBUNIT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL ISOLATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; GP130 GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

DOWN-REGULATION; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HUMANS; INFLAMMATION; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84866661780     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045706     Document Type: Article

References (30)

1. Batten M, Ghilardi N, (2007) The biology and therapeutic potential of interleukin 27. J Mol Med 85: 661-672.
2. Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A, (2009) The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 8: 40-52.
3. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, et al. (2004) WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 172: 2225-2231.
4. Demyanets S, Huber K, Wojta J, (2012) Vascular effects of glycoprotein130 ligands- Part I: Pathophysiological role. Vascul Pharmacol 56: 34-46.
5. Chen Q, Ghilardi N, Wang H, Baker T, Xie MH, et al. (2000) Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407: 916-920.
6. Sprecher CA, Grant FJ, Baumgartner JW, Presnell SR, Schrader SK, et al. (1998) Cloning and characterization of a novel class I cytokine receptor. Biochem Biophys Res Commun 246: 82-90.
7. Wirtz S, Tubbe I, Galle PR, Schild HJ, Birkenbach M, et al. (2006) Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med 203: 1875-1881.
8. Larousserie F, Charlot P, Bardel E, Froger J, Kastelein RA, et al. (2006) Differential effects of IL-27 on human B cell subsets. J Immunol 176: 5890-5897.
9. Lucas S, Ghilardi N, Li J, de Sauvage FJ, (2003) IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and-independent mechanisms. Proc Natl Acad Sci U S A 100: 15047-15052.
10. Ruckerl D, Hessmann M, Yoshimoto T, Ehlers S, Holscher C, (2006) Alternatively activated macrophages express the IL-27 receptor alpha chain WSX-1. Immunobiology 211: 427-436.
11. Guzzo C, Ayer A, Basta S, Banfield BW, Gee K, (2012) IL-27 Enhances LPS-Induced Proinflammatory Cytokine Production via Upregulation of TLR4 Expression and Signaling in Human Monocytes. J Immunol 188: 864-873.
12. Guzzo C, Che Mat NF, Gee K, (2010) Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes. J Biol Chem 285: 24404-24411.
13. Greenwell-Wild T, Vazquez N, Jin W, Rangel Z, Munson PJ, et al. (2009) Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 114: 1864-1874.
14. Imamichi T, Yang J, Huang DW, Brann TW, Fullmer BA, et al. (2008) IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages. AIDS 22: 39-45.
15. Guzzo C, Hopman WM, Mat NF, Wobeser W, Gee K, (2010) Impact of HIV infection, highly active antiretroviral therapy, and hepatitis C coinfection on serum interleukin-27. AIDS 24: 1371-1374.
16. Schneider R, Yaneva T, Beauseigle D, El-Khoury L, Arbour N, (2011) IL-27 increases the proliferation and effector functions of human naive CD8+ T lymphocytes and promotes their development into Tc1 cells. Eur J Immunol 41: 47-59.
17. Wong CK, Chen da P, Tam LS, Li EK, Yin YB, et al. (2010) Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 12: R129.
18. Murugaiyan G, Mittal A, Lopez-Diego R, Maier LM, Anderson DE, et al. (2009) IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 183: 2435-2443.
19. de Arquer GR, Pena R, Cabrera C, Coma G, Ruiz-Hernandez R, et al. (2007) Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patients. J Leukoc Biol 82: 72-78.
20. Jones ML, Young JM, Huang QR, Puls RL, Webber CA, et al. (2003) Interleukin 12-augmented T cell proliferation of peripheral blood mononuclear cells from HIV-seropositive individuals is associated with interleukin 12 receptor beta 2 upregulation. AIDS Res Hum Retroviruses 19: 283-292.
21. Tjernlund A, Fleener Z, Behbahani H, Connick E, Sonnerborg A, et al. (2003) Suppression of leukemia inhibitor factor in lymphoid tissue in primary HIV infection: absence of HIV replication in gp130-positive cells. AIDS 17: 1303-1310.
22. McQuaid A, Tormey VJ, Trafford B, Webster AD, Bofill M, (2003) Evidence for increased expression of regulatory cytokine receptors interleukin-12R and interleukin-18R in common variable immunodeficiency. Clin Exp Immunol 134: 321-327.
23. Alhetheel A, Yakubtsov Y, Abdkader K, Sant N, Diaz-Mitoma F, et al. (2008) Amplification of the signal transducer and activator of transcription I signaling pathway and its association with apoptosis in monocytes from HIV-infected patients. AIDS 22: 1137-1144.
24. Baqui AA, Jabra-Rizk MA, Kelley JI, Zhang M, Falkler WA Jr, et al. (2000) Enhanced interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by LPS stimulated human monocytes isolated from HIV+ patients. Immunopharmacol Immunotoxicol 22: 401-421.
25. Birx DL, Redfield RR, Tencer K, Fowler A, Burke DS, et al. (1990) Induction of interleukin-6 during human immunodeficiency virus infection. Blood 76: 2303-2310.
26. Sadeghi HM, Weiss L, Kazatchkine MD, Haeffner-Cavaillon N, (1995) Antiretroviral therapy suppresses the constitutive production of interleukin-1 associated with human immunodeficiency virus infection. J Infect Dis 172: 547-550.
27. Canque B, Rosenzwajg M, Gey A, Tartour E, Fridman WH, et al. (1996) Macrophage inflammatory protein-1alpha is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood 87: 2011-2019.
28. Feng XM, Liu N, Yang SG, Hu LY, Chen XL, et al. (2008) Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27. BiochemBiophysResCommun.
29. Tilton JC, Johnson AJ, Luskin MR, Manion MM, Yang J, et al. (2006) Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons. J Virol 80: 11486-11497.
30. von Sydow M, Sonnerborg A, Gaines H, Strannegard O, (1991) Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses 7: 375-380.